Gamco Investors INC. ET AL decreased its stake in Seagen Inc. (NASDAQ:SGEN – Free Report) by 4.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,560 shares of the biotechnology company’s stock after selling 840 shares during the quarter. Gamco Investors INC. […]
Howe & Rusling Inc. lowered its holdings in shares of Seagen Inc. (NASDAQ:SGEN – Free Report) by 7.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,772 shares of the biotechnology company’s stock after selling 142 shares during the period. Howe & Rusling Inc.’s […]
Pekin Hardy Strauss Inc. grew its position in shares of Seagen Inc. (NASDAQ:SGEN – Free Report) by 19.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,620 shares of the biotechnology company’s stock after purchasing an additional 900 shares during the […]
Versor Investments LP trimmed its holdings in Seagen Inc. (NASDAQ:SGEN – Free Report) by 56.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,719 shares of the biotechnology company’s stock after selling 42,124 shares during the quarter. Seagen accounts for 1.4% of Versor Investments […]
StockNews.com began coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a report released on Wednesday. The firm issued a hold rating on the biotechnology company’s stock. Several other equities analysts also recently issued reports on SGEN. Truist Financial restated a hold rating and issued a $229.00 price objective on shares of Seagen in […]